Title |
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
Institution |
BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX
|
Principal Investigator |
LIN, WEEI-CHIN
|
NCI Program Director |
Pelroy
|
Cancer Activity |
DNA Chromosome Aberrations
|
Division |
DCB
|
Funded Amount |
$362,569
|
Project Dates |
12/15/2016 - 11/30/2021
|
Fiscal Year |
2017
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
|
Breast (75.0%)
Ovarian Cancer (25.0%)
|
Research Type |
Cancer Initiation: Alterations in Chromosomes
Systemic Therapies - Discovery and Development
|
Abstract |
No abstract available. |